TAGITOL V Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tagitol V, and what generic alternatives are available?
Tagitol V is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in TAGITOL V is barium sulfate. One supplier is listed for this compound. Additional details are available on the barium sulfate profile page.
Summary for TAGITOL V
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 104 |
Patent Applications: | 9 |
Formulation / Manufacturing: | see details |
What excipients (inactive ingredients) are in TAGITOL V? | TAGITOL V excipients list |
DailyMed Link: | TAGITOL V at DailyMed |
Pharmacology for TAGITOL V
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
US Patents and Regulatory Information for TAGITOL V
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | TAGITOL V | barium sulfate | SUSPENSION;ORAL | 208143-005 | Aug 4, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |